Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ERG Holding is the parent company behind Evolution Research Group, an independent U.S. clinical research site and clinical development services organization rather than a therapeutics developer. The business operates a nationwide network of owned and affiliated clinical research units that execute inpatient and outpatient Phase I-IV trials, with particular strength in central nervous system disorders, pain, addiction, sleep, metabolic disease, and other specialized populations. ERG also includes complementary service businesses such as Lotus Clinical Research, a full-service CRO, and CNS Ratings, a rater training and surveillance company. Its value proposition centers on centralized trial operations, harmonized SOPs, specialized facilities, scientific leadership, and access to diverse patient populations to support pharmaceutical and biotechnology sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ERG Holding.